Results 21 to 30 of about 13,250 (212)

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis. [PDF]

PLoS ONE, 2014
The β2-adrenergic receptor agonist, albuterol, has been reported beneficial in treating several forms of congenital myasthenia. Here, for the first time, we examined the potential benefit of albuterol in a mouse model of anti-Muscle Specific Kinase (MuSK)
Nazanin Ghazanfari, Marco Morsch, Nigel Tse, Stephen W Reddel, William D Phillips   +4 more
doaj   +1 more source

Nebulized heparin and salbutamol versus salbutamol alone in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation: a double-blind randomized controlled trial [PDF]

Korean Journal of Anesthesiology, 2020
Background Nebulized heparin has been effectively used in the management of many pulmonary diseases. However, its effect on mechanically ventilated patients with acute exacerbation chronic obstructive pulmonary disease (AECOPD) has never been studied ...
Tarek Mohamed Ashoor, Ahmad Mahmoud Hasseb, Ibrahim Mamdouh Esmat   +2 more
doaj   +1 more source

Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma

Respiratory Research, 2011
Background Inhaled short acting β2-agonists (SABA), e.g. albuterol, are used for quick reversal of bronchoconstriction in asthmatics. While SABA are not recommended for maintenance therapy, it is not uncommon to find patients who frequently use SABA over
Aimi Steven, Wu Min, Riesenfeld Erik P, Poynter Matthew E, Rinaldi Lisa M, Lundblad Lennart KA, Barone Leesa M, Bates Jason HT, Irvin Charles G   +8 more
doaj   +1 more source

Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry

Scientific Reports, 2023
Airsupra inhalation aerosol is a recently approved FDA medication that combines albuterol and budesonide for treating or preventing bronchoconstriction and lowering the risk of relapses in asthma patients who are 18 years of age and older. To selectively
Atiah H. Almalki, Sherif Ramzy, Ahmed A. Almrasy   +2 more
doaj   +1 more source

Effect of inhaled albuterol on whole blood potassium concentrations in dogs

Journal of Veterinary Internal Medicine, 2022
Background Albuterol by inhalation (IH) is a common treatment for hyperkalemia in humans but its effect on blood potassium concentrations in dogs is unknown.
Andrzej Ogrodny, Jared A. Jaffey, Rachael Kreisler, Mark Acierno, Teela Jones, Renata S. Costa, Anderson daCunha, Emily Westerback   +7 more
doaj   +1 more source

Myoclonus induced by salbutamol: A case report

Biomédica: revista del Instituto Nacional de Salud, 2018
Salbutamol is a β2 adrenergic agonist widely prescribed in patients with obstructive and restrictive lung diseases. The main side effects associated with its use are tachycardia and tremor. Myoclonus is an involuntary, irregular, abrupt, brief and sudden
María Alejandra Montoya-Giraldo, Dayana Vanessa Montoya, David Alexander Atehortúa, Jefferson Antonio Buendía, Andrés Felipe Zuluaga   +4 more
doaj   +1 more source

Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome

Journal of Research in Medical Sciences, 2023
Background: In addition to surfactant deficiency, secretion of fluid from blood to the lungs and increase in the fluid content of the lung play significant roles in the pathogenesis of respiratory distress syndrome (RDS).
Razieh Moazami Goudarzi, Zohreh Badiee, Alireza Sadeghnia, Behzad Barekatain   +3 more
doaj   +1 more source

Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma

, 2022
Background: As asthma symptoms worsen, patients typically rely on short-acting β2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma exacerbations.
Cooper, Mark, Beasley, Richard, Johnsson, Eva, Chipps, Bradley E, Israel, Elliot, Albers, Frank C, Jeynes-Ellis, Allison, Cappelletti, Christy, Papi, Alberto, Rees, Robert, Dunsire, Lynn, Panettieri, Reynold A   +11 more
core   +1 more source

Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells

Frontiers in Endocrinology, 2015
Airway epithelial NF-kB activation is observed in asthmatic subjects and is a cause of airway inflammation in mouse models of allergic asthma. Combination therapy with inhaled short-acting b2-agonists and corticosteroids significantly improves lung ...
Matthew J Randall, Shannon F Kostin, Edward J Burgess, Laura R Hoyt, Jennifer L Ather, Lennart K Lundblad, Matthew E Poynter   +6 more
doaj   +1 more source

Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study

BJGP Open, 2023
Background: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma.
Paul Pfeffer, Hajar Hajmohammadi, James Cole, Chris Griffiths, Sally Hull, Anna De Simoni   +5 more
doaj   +1 more source